The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-0814-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2015English

Progress in Adjuvant Chemotherapy for Breast Cancer: An Overview

BMC Medicine
Medicine
2015English

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients With Early Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Does Timing of Adjuvant Chemotherapy Influence the Prognosis After Early Breast Cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

British Journal of Cancer
Cancer ResearchOncology
2005English

Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List

Journal of Oncology Practice
Health PolicyOncology
2019English

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70

PLoS ONE
Multidisciplinary
2015English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine
Medicine
2005English

Immortalization-Associated Gene Signature in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy